Back to 
Wolverine Trading, LLC
Wolverine Trading, LLC
CRVS
Showing 0 of 2 quarters
Position history for Wolverine Trading, LLC's holdings in Corvus Pharmaceuticals, Inc.
No. Wolverine Trading exited its CRVS (Corvus Pharmaceuticals) position in Q4 2022. Its Q3 2022 13F listed 10,688 shares worth $8,000. Wolverine Trading first reported CRVS in Q3 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.